NEW YORK, April 19 (GenomeWeb News) - Shares in Sequenom were trading up 10.3 percent, or $.10, at $1.11 in early afternoon trading on news that the company has developed a process to identify epigenetic markers in lung cancer.
Already have a GenomeWeb or 360Dx account?Login Now.
Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.
The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.
Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.
In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.